Introduction
Protein tyrosine phosphorylation plays a crucial role in cell regulation and signal transduction. In cells, the extent of tyrosine phosphorylation of a protein is controlled by the steady state of activities of both protein tyrosine kinases and protein tyrosine phosphatases (PTPase). The shift of this steady state by growth factors, cytokines, and enzyme activators/inhibitors enhances or decreases the phosphorylation state of key signaling molecules and initiates or regulates various biological processes (Hunter, 1998) .
The IR tyrosine kinase is activated upon insulin stimulation, and the activated tyrosine kinase phosphorylates various downstream signaling molecules such as the IRS proteins (Cheatham and Kahn, 1995; White, 1998) . Tyrosine phosphorylation of the IR also generates binding sites for SH2-domain-containing proteins such as Shc (Cheatham and Kahn, 1995; White, 1998) and Grb10 (Liu and Roth, 1998) .
Grb10 is a SH2 and PH domain-containing protein that binds to autophosphorylated receptor tyrosine kinases including the IR (Frantz et al., 1997; Hansen et al., 1996; Laviola et al., 1997; Liu and Roth, 1995; O'Neill et al., 1996) , IGF-1R (Frantz et al., 1997; Morrione et al., 1996; O'Neill et al., 1996) , ELK (Stein et al., 1996) , and Ret (Durick et al., 1996; Pandey et al., 1995) . Grb10 also binds to receptor downstream signaling components such as BCR ± ABL (Bai et al., 1998) , Raf-1 and MEK (Nantel et al., 1998) , and Nedd4 (Morrione et al., 1999) . Overexpression of the full-length Grb10 stimulates PDGF, IGF-1, and insulin-induced DNA synthesis, suggesting Grb10 may play an important role in growth factor-mediated mitogenesis (Wang et al., 1999) . The ®ndings that Grb10 interacts with multiple signaling molecules and that the protein undergoes tetramerization in cells (Dong et al., 1998) also suggest that the protein may function as an adaptor/scaolding protein in various cellular signaling processes. Several isoforms of Grb10 have recently been identi®ed from human tissues which include hGrb10a, hGrb10b, and hGrb10g. HGrb10a, originally named Grb-IR, was identi®ed by screening a yeast two-hybrid library derived from HeLa cells using the cytoplasmic domain of the IR as a bait (Liu and Roth, 1995) . This isoform diers from hGrb10g by a 46-amino acid deletion in the PH domain, possibly due to alternative splicing events. Both isoforms of Grb10 bind to the autophosphorylated IR and the interaction is mediated by the SH2 domain of Grb10. We (Dong et al., 1997b) and others (O'Neill et al., 1996) have shown that, unlike other SH2 domain-containing adaptor proteins, Grb10 binds to the autophosphorylated tyrosine residues in the activation loop of the IR. We have also found that Grb10 is serine phosphorylated in cells and that this serine phosphorylation can be stimulated by insulin treatment (Dong et al., 1997a) . However, whether Grb10 also undergoes growth factor-stimulated tyrosine phosphorylation remains to be established. Phosphoamino acid analysis revealed that mouse Grb10 was phosphorylated exclusively on serine residues before and after EGF treatment (Ooi et al., 1995) . On the other hand, we (Liu and Roth, 1995) and others (Frantz et al., 1997) have found that a phosphotyrosine-containing protein, which was immunoprecipitated by the anti-Grb10 antibody, comigrated with Grb10. Although this ®nding suggests that Grb10 may be tyrosine phosphorylated in cells, it is also possible that another tyrosine phosphorylated protein, rather than Grb10 itself, coimmunoprecipitated with Grb10.
To further understand the potential roles of Grb10, we investigated the tyrosine phosphorylation of two human Grb10 isoforms, hGrb10a (Liu and Roth, 1995) and hGrb10g (Dong et al., 1997a) . In this report, we present evidence that Grb10 is tyrosine phosphorylated in cells in response to the treatment of insulin and PTPase inhibitors. However, we have found that Grb10 is not a direct substrate for the IR tyrosine kinase and the tyrosine phosphorylation of Grb10 is independent of its binding to the IR in cells. We provide evidence that Grb10 is a substrate for Src and Fyn in vitro and is a potential physiological target for these kinases in cells. The identi®cation of Grb10 as a new target for Src tyrosine kinase family members may suggest a potential role for the involvement of Grb10 in various biological events mediated by these tyrosine kinases.
Results

Grb10 isoforms underwent insulin and pervanadate-stimulated tyrosine phosphorylation in cells
In our previous studies, we detected a phosphotyrosine-containing protein in the immunoprecipitates from insulin-stimulated CHO/IR/Grb10a cell lysates using antibody against Grb10 (Liu and Roth, 1995) . However, whether this immunoprecipitated protein was Grb10 itself, or another tyrosine phosphorylated protein which might co-immunoprecipitate with Grb10, was unclear. To test whether Grb10 was tyrosine phosphorylated in cells, we carried out studies in the presence of sodium orthovanadate and pervanadate, inhibitors of protein tyrosine phosphatases. As expected, treatment of CHO/IR cells with insulin led to the tyrosine phosphorylation of several proteins, including the 95 kDa IR b-subunit and the 185 kDa IRS-1 (Figure 1a , lane 4). The tyrosine phosphorylation of cellular proteins was substantially increased in the presence of pervanadate, an irreversible inhibitor of PTPases (Huyer et al., 1997) (Figure 1a , lanes 5 and 6). However, little tyrosine phosphorylation was detected in lysates from non-treated cells ( Figure 1a , lane 1) or from cells treated with vanadate or H 2 O 2 alone ( Figure  1a , lanes 2 and 3).
To examine whether Grb10 was tyrosine phosphorylated in cells, we treated CHO/IR/hGrb10a and CHO/ IR/hGrb10g cells with vanadate or pervanadate. In insulin and vanadate-treated CHO/IR/hGrb10a cells, the anti-Grb10 antibody precipitated two phosphotyrosine-containing proteins with molecular masses of 62 and 64 kDa, respectively (Figure 1b, upper panel, lane 5) . Stripping and reblotting of the same membrane with antibody to the HA tag revealed that the 62 kDa protein was hGrb10a (Figure 1b , lower panel, lanes 1 ± 6). The 64 kDa protein, which was not recognized by the anti-HA antibody, co-migrated with hGrb10g ( Figure 1b , upper panel, lanes 7 ± 12), suggesting that it was probably the endogenous Grb10. The tyrosine phosphorylation of the Grb10 isoforms was further stimulated by treating cells with pervanadate (Figure 1b, upper panel, lanes 6 and 12) . A small amount of tyrosine phosphorylation of Grb10 was observed when the cells were treated with insulin alone (Figure 1b , upper panels, lanes 4 and 10). On the other hand, vanadate and H 2 O 2 alone had essentially no eect on Grb10 tyrosine phosphorylation (Figure 1b, upper panel, lanes 2, 3, 8, and 9) . Similar results were also observed in CHO, HEK293, Rat1-IR, and NIH3T3-IR cells expressing endogenous Grb10 (data not shown).
Grb10 is not a direct substrate for the IR tyrosine kinase
To determine the mechanism of the tyrosine phosphorylation, we followed the time course of insulin and vanadate-stimulated tyrosine phosphorylation of the 78 M insulin plus 0.1 mM pervanadate (lane 6). Treatment lasted for 10 min with insulin and pervanadate and 30 min with the rest. Cells were lysed in 150 ml SDS ± PAGE gel loading buer and total cell lysates (1.5 ml for lysate from pervanadate-treated cells and 15 ml with the rest) were separated by SDS ± PAGE, transferred onto a nitrocellulose membrane, and blotted with anti-phosphotyrosine antibody. (b) Tyrosine phosphorylation of HA-tagged human Grb10. CHO/IR/hGrb10a (lanes 1 ± 6) or CHO/IR/hGrb10g (lanes 7 ± 12) cells grown in 60 mm plates were left untreated (lanes 1 and 7) or treated with 1 mM Na 3 VO 4 (lanes 2 and 8), 1 mM H 2 O 2 (lanes 3 and 9), 10 78 M insulin (lanes 4 and 10), 10 78 M insulin plus 1 mM Na 3 VO 4 (lanes 5 and 11), or 0.1 mM pervanadate (lanes 6 and 12). Grb10 isoforms were immunoprecipitated with antibody to the protein, separated by SDS ± PAGE, and the tyrosine phosphorylation of the protein was visualized with antibody to phosphotyrosine (upper panel). The same membrane was stripped and reblotted with antibody to the HA-tag to ensure equal loading of the protein in each lane (lower panel). MM, molecular mass osine phosphorylation could be detected as early as 5 min. Similar ®ndings were also observed for hGrb10 isoforms overexpressed in CHO/IR cells (data not shown).
Because Grb10 binds to the kinase domain of the IR (Dong et al., 1997b; O'Neill et al., 1996) , we were interested in determining whether Grb10 was a direct substrate of the receptor tyrosine kinase. First we examined if Grb10 could be phosphorylated by puri®ed IR in vitro. The IR was puri®ed from CHO/IR cells by wheat germ agglutinin-gel absorption and activated in vitro according to a previously described protocol (Zhang et al., 1991) . Phosphorylation of the His-tagged hGrb10g by the activated IR was performed in the presence of divalent metal ions and 32 P-g-ATP. As a control, we also tested the phosphorylation of His-tagged p62 dok (Carpino et al., 1997; Yamanashi and Baltimore, 1997) , a p21 ras GAPassociated protein that is tyrosine phosphorylated after insulin stimulation (Hosomi et al., 1994) . While incubation of the activated IR with p62 dok bound to Ni-NTA-agarose beads resulted in a marked increase in the tyrosine phosphorylation of the protein, no notable tyrosine phosphorylation of Grb10 was observed under the same condition (data not shown). To further characterize Grb10 tyrosine phosphorylation, we expressed a mutant hGrb10g in which a critical arginine residue in the SH2 domain was changed to glutamate (hGrb10g
R520E
). This mutant of hGrb10 did not bind the IR in the yeast two-hybrid system (Dong et al., 1997b) Figure 3a , lanes 4, and 8). These tyrosine phosphorylated proteins could be pulled-down by the SH2 domain of Grb10 fused with GST (GST/Grb10-SH2) (data not shown), suggesting that the interaction may be mediated by the phosphotyrosine residues on these proteins and the SH2 domain of Grb10. Western blot revealed that the 185 kDa protein was IRS-1 and the 95 kDa protein was the b-subunit of the IR (data not shown and Figure 3b ), respectively. However, the identities of the other tyrosine phosphorylated proteins are currently unknown. Nevertheless, the mutant hGrb10g, which could no longer interact with the IR, was still tyrosine phosphorylated in response to treatment with vanadate and insulin ( Figure 3a , lane 11) or pervanadate alone ( Figure 3a , lane 12). Taken together, these ®ndings suggest that Grb10 tyrosine phosphorylation was probably mediated by an IR downstream kinase(s) rather than by the IR tyrosine kinase itself. It is interesting to note that a smaller amount of the IR was co-immunoprecipitated in the pervanadate-treated cells (Figure 3b , lanes 4 and 8), suggesting that either tyrosine phosphorylation of Grb10 or excessive tyrosine phosphorylation of the IR may negatively regulate the interaction between these two proteins. insulin for the indicated times. Grb10 was immunoprecipitated with antibody to the protein, separated by SDS ± PAGE, and blotted to a nitrocellulose membrane. Tyrosine phosphorylation of Grb10 was visualized by Western blot with antibody to phosphotyrosine (upper panel). The same membrane was stripped and reblotted with antibody to Grb10 to document equal loading. (b) Pervanadate stimulated tyrosine phosphorylation of Grb10 isoforms. CHO/IR cells grown in 100 mm tissue culture plates were serum starved for 1 h at 378C and treated with pervanadate for the indicated times. The tyrosine phosphorylated Grb10 was immunoprecipitated by antibody to Grb10, separated by SDS ± PAGE, blotted to a nitrocellulose membrane, and detected with antibody to phosphotyrosine (upper panel) or to Grb10 (lower panel) Figure 3 Tyrosine phosphorylation of Grb10 is independent of its binding to the IR in cells. Cells expressing the IR and hGrb10a (lanes 1 ± 4), the IR and hGrb10g (lanes 5 ± 8), or the IR and hGrb10g R520E (lanes 9 ± 12) were grown in 100 mm plates to subcon¯uence, serum starved for 1 h, and left untreated or treated with 10 78 M insulin, 1 mM Na 3 VO 4 plus 10 78 M insulin, and 0.1 mM pervanadate as indicated. Grb10 proteins were immunoprecipitated with antibody to the HA-tag, separated by SDS ± PAGE, and transferred to a nitrocellulose membrane. The tyrosine phosphorylation of Grb10 was visualized by Western blot with antibody to phosphotyrosine (a). The same membrane was re-blotted with antibody to the b-subunit of the insulin receptor (b) or to Grb10 (c). MM, molecular mass Tyrosine phosphorylation of Grb10 by members of the Src tyrosine kinase family, Src and Fyn
To identify the tyrosine kinase(s) that phosphorylated Grb10, we examined whether herbimycin A, a selective inhibitor for the Src tyrosine kinase family (Uehara et al., 1985) , blocked insulin-stimulated Grb10 tyrosine phosphorylation. As shown in Figure 4a , in the absence of herbimycin A, insulin and vanadate stimulation resulted in the tyrosine phosphorylation of Grb10 (lane 1). However, the insulin and vanadatestimulated tyrosine phosphorylation was signi®cantly inhibited when cells were pretreated with herbimycin A for 3 h (Figure 4a , lane 2) and was completely blocked after pretreatment of the cells for 24 h (Figure 4a , lane 3). Herbimycin treatment also led to a decrease in pervanadate-stimulated tyrosine phosphorylation of Grb10g in CHO/IR cells (Figure 4b ).
To further test whether Src was involved in Grb10 tyrosine phosphorylation, we transiently co-transfected CHO/IR cells with hGrb10g and constitutively active (Src . Forty-eight hours after transfection, cells were serum starved for 3 h in the presence or absence of 3 mM herbimycin A. After treatment, cells were lysed in Buer A and hGrb10g was immunoprecipitated with antibody to the HA-tag. One-third of the immunoprecipitates were separated by SDS ± PAGE and analysed by Western blot with anti-phosphotyrosine antibody (top panel). One-third of the immunoprecipitates were used for Western blot with a monoclonal antibody to the HA-tag (bottom panel) 4c, lanes 5 and 6). Similar results were also obtained for cells overexpressing a constitutively active ( Figure  4d , lanes 3 and 4) or a dominant negative Fyn mutant (Figure 4d , lanes 5 and 6). The Src-or Fyn-stimulated tyrosine phosphorylation of Grb10g was also reduced by treatment of cells with herbimycin A (Figure 4e ). These ®ndings provide further evidence that the insulin-stimulated tyrosine phosphorylation of Grb10 is probably mediated by members of the Src tyrosine kinase family such as Src and Fyn.
To determine whether Grb10 was a direct substrate for members of the Src kinase family, we carried out in vitro phosphorylation studies using puri®ed Src and Grb10. As shown in Figure 5a , incubation of GSThGrb10g bound to glutathione agarose beads with Src resulted in a time-dependent tyrosine phosphorylation of hGrb10g. Phosphoamino acid analysis indicated that the phosphorylation was entirely on tyrosine residues (Figure 5b ). Similar results were obtained when the in vitro phosphorylation was carried out using puri®ed Fyn tyrosine kinase (data not shown).
Identification of tyrosine 67 in Grb10 as the Src/Fyn-catalyzed phosphorylation site
Having found that Grb10 was a direct substrate for Src and Fyn, we then attempted to identify the tyrosine phosphorylation site(s) on the protein. To narrow down the region of the tyrosine phosphorylation, we compared the phosphorylation of the full-length and a carboxyl terminal truncated form of Grb10. This mutant form of Grb10 had a 180 amino acid-deletion in the carboxyl terminus, including the SH2 domain (Figure 6a ). We found that Src phosphorylated this mutant form of Grb10 (hGrb10gDC) as eciently as the full-length protein (Figure 6b) , suggesting that the tyrosine phosphorylation site(s) may be located at the amino terminus. Analysis of the amino acid sequence of hGrb10gDC revealed the presence of 12 tyrosine residues and one of them, Tyr 67 , appeared to be a potential candidate for tyrosine kinases. This residue is preceded by a hydrophobic leucine at the 71 and a negatively charged glutamate at the 73 positions, respectively (Figure 6a ), which constitute an optimal substrate sequence for members of the Src tyrosine kinase family (Ruzzene et al., 1997; Songyang and Cantley, 1995) . Quite recently, this residue was shown to be tyrosine phosphorylated by Tec tyrosine kinase (Mano et al., 1998) . To test whether Tyr 67 in hGrb10g -GST fusion proteins conjugated to glutathione beads were phosphorylated as described in the legends of Figure  5a . A similar protocol was employed for Fyn-catalyzed Grb10 phosphorylation, except Buer D was used. After separation by SDS ± PAGE, the gels were stained with Coomassie blue (bottom panel) and the phosphorylation of Grb10 was visualized by autoradiography (top panel) Figure 5 Identi®cation of Grb10 as a direct substrate of Src. (a) Time course study of Grb10 phosphorylation by Src in vitro. GST-hGrb10g fusion protein bound to glutathione agarose beads was washed once with 50 mM HEPES, pH 7.6, and twice with Buer C. In vitro kinase assays were initiated by adding 30 ml Buer C containing 25 mM ATP, 2 mCi 32 P-g-ATP, and 1 unit of Src. Reactions were carried out at 308C for times indicated. Reactions were stopped by adding SDS loading buer and boiling at 958C for 3 min. Samples were separated by SDS ± PAGE, transferred to a nitrocellulose membrane, and phosphorylation was visualized by autoradiography (insert). The incorporation of 32 P into the GST-hGrb10g fusion protein was quanti®ed by PhosphorImager analysis. (b) Phosphoamino analysis of in vitro phosphorylated Grb10. The 32 P-labeled hGrb10g bands were excised from the membrane, hydrolyzed and analysed by twodimensional thin-layer electrophoresis and autoradiography Oncogene Tyrosine phosphorylation of Grb10 P Langlais et al was the site of phosphorylation by Src or Fyn, we replaced it with a glycine by site-directed mutagenesis. The mutant form of Grb10 was expressed in bacterial cells as a GST-fusion protein, puri®ed by glutathione agarose beads, and tested for phosphorylation by Src and Fyn kinases in vitro. As shown in Figure 6c , while the wild-type Grb10 was readily phosphorylated by both Src and Fyn tyrosine kinases, no tyrosine phosphorylation could be detected for the GSTGrb10 Y67G mutant, suggesting that Tyr 67 was the Src/ Fyn-catalyzed phosphorylation site in Grb10.
To con®rm that Tyr 67 was the tyrosine phosphorylation site in vivo, we subcloned the cDNA encoding the mutant of hGrb10g into a mammalian expression vector (pBEX) (Bram et al., 1993) and transiently expressed the HA-tagged wild-type or the mutant proteins in CHO/IR cells. Replacing tyrosine at position 67 with glycine did not signi®cantly alter the overall structure of the protein since the insulinstimulated gel mobility shift, which was caused mainly by wortmannin and PD98059-sensitive serine phosphorylation (Dong et al., 1997a) , was similar to that of the wild-type protein (data not shown). Cells expressing the wild-type or the mutant hGrb10g (hGrb10g Y67G ) were treated with or without insulin, vanadate, or pervanadate and the tyrosine phosphorylated Grb10 was examined by anti-phosphotyrosine blot of anti-HA immunoprecipitates. As shown in Figure 7a , treatment of cells with insulin and vanadate (lane 5) or pervanadate (lane 7) resulted in a signi®cant increase in tyrosine phosphorylation of the wild-type Grb10. The insulin/vanadate- (Figure 7a , lanes 5 and 6), Src- (Figure 7b, lanes 1 and 2) , or Fyn- (Figure 7b , lanes 3 and 4) stimulated tyrosine phosphorylation, however, was notably decreased for the hGrb10g Y67G mutant. The pervanadate-induced tyrosine phosphorylation of hGrb10g Y67G was also decreased signi®cantly ( Figure 7a, lane 8) . However, residual tyrosine phosphorylation could still be observed for this mutant, indicating that additional site(s) may be tyrosine phosphorylated in response to pervanadatetreatment.
Tyrosine phosphorylation of Grb10 inhibits the binding of the protein to the IR As mentioned earlier, pervanadate-stimulated tyrosine phosphorylation resulted in a decrease in the amount of IR co-immunoprecipitated with Grb10 (Figure 3b,  lanes 4 and 8) . This ®nding suggested that either tyrosine phosphorylation of Grb10 or excessive tyrosine phosphorylation of the IR may aect the binding of the adaptor protein to the receptor. To further test this idea, we examined the interaction between the IR and hGrb10g or the hGrb10g Y67G mutant. Consistent with our previous ®ndings, insulin-stimulation of CHO/IR cells expressing the wild-type hGrb10g resulted in a signi®cant increase of the tyrosine phosphorylated IR, which could be co-immunoprecipitated with hGrb10g ( Figure 7c, lane 3) . The insulinstimulated IR/Grb10 interaction was enhanced in cells overexpressing hGrb10g
Y67G (Figure 7c, lane 4) . The enhanced interaction between the IR and the mutant Grb10 was also observed in cells treated with insulin plus vanadate (Figure 7c , lanes 5 and 6) or pervanadate alone (Figure 7c, lanes 7 and 8) . These ®ndings provide further evidence that tyrosine phosphorylation of Grb10 inhibits the binding of the protein to the IR. 78 M insulin (lanes 3 and 4), 1 mM Na 3 VO 4 plus 10 78 M insulin (lanes 5 and 6), or 0.1 mM pervanadate (lanes 7 and 8). The treatment was 30 min for vanadate and 10 min for the rest. After treatment, cells were lysed in Buer A and both hGrb10g and hGrb10g Y67G were immunoprecipitated with antibody to the HA-tag. The proteins were separated by SDS ± PAGE and transferred to a nitrocellulose membrane. Tyrosine phosphorylation of hGrb10g or hGrb10g . Forty-eight hours after transfection, cells were serum starved for 1 h. Cells were then lysed in Buer A and both hGrb10g and hGrb10g Y67G were immunoprecipitated with antibody to the HA-tag. One-third of the immunoprecipitates were separated by SDS ± PAGE and analysed by Western blot with anti-phosphotyrosine antibody (top panel). One-third of the immunoprecipitates were used for Western blot with a monoclonal antibody to the HA-tag (bottom panel). (c) Association of the IR with the wild-type or the tyrosine phosphorylation site mutant of Grb10. In the same experiment described in (a), the tyrosine phosphorylated IR co-immunoprecipitated with hGrb10g (lanes 3, 5 and 7) or hGrb10g Y67G (lanes 4, 6 and 8) was detected with antibody to phosphotyrosine (upper panel). The same membrane was stripped and reblotted with antibody to the b-subunit of the IR (lower panel)
Discussion
In this report we demonstrate that Grb10 is tyrosine phosphorylated in cells in response to insulin stimulation. Although the adapter protein binds directly to the kinase domain of the IR (Dong et al., 1997b) , the present results suggest that tyrosine phosphorylation of Grb10 is mediated by a downstream kinase(s), rather than the IR tyrosine kinase itself. We present evidence that members of the Src tyrosine kinase family, such as Src and Fyn, may be potential kinases that phosphorylate Grb10. First, Grb10 tyrosine phosphorylation was stimulated by overexpression of a constitutively active Src or Fyn in cells (Figure  4c,d ). In addition, the phosphorylation was inhibited by herbimycin A (Figure 4a,b,e) , a relatively speci®c inhibitor of Src tyrosine kinase family members (Uehara et al., 1985) , and by overexpression of a dominant negative mutant of Src or Fyn (Figure  4c,d) . Furthermore, Grb10 was directly phosphorylated by the puri®ed Src and Fyn in vitro ( Figure 5 ). Finally, replacement of Tyr 67 with glycine in Grb10, which abrogated the Src/Fyn-catalyzed phosphorylation of Grb10 in vitro (Figure 6c) , also reduced the insulin-stimulated tyrosine phosphorylation in cells (Figure 7a,b) . However, while our data suggest that Grb10 is a potential target for Src and Fyn, these ®ndings do not exclude the possibility that other members of the Src tyrosine kinase family may also phosphorylate Grb10 in cells.
In the present study, we provide further evidence that the interaction between Grb10 and the IR is dependent on the SH2 domain of the protein and the autophosphorylated tyrosine residues in the receptor (Figure 3 ). Although we have previously shown that the carboxyl terminus of Grb10, which contains the SH2 domain, was sucient to bind to the autophosphorylated IR (Liu and Roth, 1995) , there is evidence suggesting that the insert between the SH2 and the PH domains (BPS) may also be involved in the binding of the protein to the receptor (He et al., 1998) . However, it is unknown whether this region is sucient to bind the IR. In this study, we have found that a single point mutation in the SH2 domain was sucient to abolish the interaction between Grb10 and the IR (Figure 3) , suggesting that the speci®city between Grb10 and the IR is mainly determined by the interaction between the SH2 domain in Grb10 and the phosphotyrosine residues in the IR. However, it is possible that an additional binding site in Grb10 may be induced after the SH2 domain binds to the receptor. Thus, the binding of the second region of Grb10 to the IR may provide additional speci®city for the interaction.
The Src tyrosine kinase family consists of at least nine members and have been shown to undergo growth factor stimulated activation in cells (Brown and Cooper, 1996) . This group of related tyrosine kinases play important roles in a variety of cellular processes, including cellular DNA synthesis, proliferation, dierentiation, and neuronal signaling (Brown and Cooper, 1996) . Most of the family members are expressed predominantly in hematopoietic cells and several of them, including Src and Fyn, are more ubiquitously expressed . Several components of the IR signaling pathway have been shown to be substrates of Src, including the adaptor protein Shc (McGlade et al., 1992) and the p85 subunit of PI3kinase (Fukui and Hanafusa, 1991; Haefner et al., 1995; Liu et al., 1993) . It has also been found that Shc is able to interact with the SH3 domain of Src through its proline rich sequence (Weng et al., 1994) . Recently, one of the members of the Src tyrosine kinase family, Fyn, has been shown to interact with IRS-1 (Sun et al., 1996) . The involvement of Src family kinases in insulin and IGF-1 signaling have also been implicated by the ®nding that the b-subunit of the IGF-1 receptor is tyrosine phosphorylated by Src (Peterson et al., 1996) . These ®ndings suggest that the Src tyrosine kinase family members may play roles in modulating molecules involved in the IR signal transduction pathway.
The binding of Grb2-Sos to tyrosine phosphorylated Shc is thought to couple the IR to Ras activation (Pronk et al., 1993; Skolnik et al., 1993) . In our study, we detected no interaction between tyrosine phosphorylated Grb10 and Grb2 (data not shown). In addition, we found that the tyrosine phosphorylation was independent of the binding of Grb10 to the IR and that Grb10 was not a direct substrate of the IR tyrosine kinase. Although Grb10 contains a prolinerich sequence that is conserved among the Grb7/ Grb10/Grb14 family members (Liu and Roth, 1998) , this sequence does not bind to the SH3 domain of Fyn, p85, or Grb2 (Frantz et al., 1997) .
In summary, we have shown that the adaptor protein Grb10 is tyrosine phosphorylated in cells and identi®ed Src and/or Fyn as two potential kinases that may catalyze the phosphorylation. The identi®cation of Grb10 as a new substrate for members of the Src tyrosine kinase family may suggest a potential role for the involvement of Grb10 in these kinase-mediated downstream biological events. However, since all these studies were carried out in CHO cells overexpressing the insulin receptor, it remains to be established whether insulin is a physiological activator of Grb10 tyrosine phosphorylation in insulin target cells such as skeletal muscle and adipocytes that express normal levels of the endogenous insulin receptor.
Materials and methods
Materials
All chemicals were purchased from Sigma unless otherwise indicated. Pervanadate was freshly prepared by mixing equal volumes of 0.1 M H 2 O 2 and 0.1 M Na 3 VO 4 and incubating for 10 min at room temperature. Monoclonal antibody to the HA-tag was from BABCO. Monoclonal antibody to Fyn, polyclonal antibodies to Src and the b-subunit of the IR were from Santa Cruz Biotechnology, Inc., (Santa Cruz, CA, USA). Antibody to phosphotyrosine was from Transduction Laboratories (Lexington, KY, USA). Polyclonal antibody to Grb10 was raised in rabbits against the C-terminus of Grb10 (amino acids 447 to 548 in hGrb10a) fused to GST and anity puri®ed as described previously (Dong et al., 1997a; Liu and Roth, 1995 ) kinases were generous gifts of Dr SA Courtneidge (Sugen, Inc, CA, USA) and have been described previously (Twamley-Sein et al., 1993) . Puri®ed Src and Fyn tyrosine kinases were from Upstate Biotechnology, Inc. (Lake Placid, NY, USA).
